mRNA Vaccine Market Report

Global and China mRNA Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 26, 2022
  • PAGES：178
  • REPORT CODE：GMM1408856
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the mRNA Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Argos Therapeutics

    • Ethris

    • eTheRNA

    • BioNTech

    • In-Cell-Art

    • Moderna Therapeutics

    • Tiba Biotechnology

    • CureVac

    • Translate Bio

    • Sangamo Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    Application:

    • Infectious Disease

    • Cancer

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 mRNA Vaccine Industry Overview

      • 1.1.1 mRNA Vaccine Market Scope and Market Segments

      • 1.1.2 mRNA Vaccine Industry Characteristics

      • 1.1.3 Global and China mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China mRNA Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global mRNA Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Standardization Of Cancer Treatment MRNA Vaccine

      • 1.2.2 Individualized Cancer Treatment MRNA Vaccine

      • 1.2.3 Infectious Disease Treatment MRNA Vaccine

      • 1.2.4 Infection Prevention MRNA Vaccine

    • 1.3 Global mRNA Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Infectious Disease

      • 1.3.2 Cancer

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global mRNA Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global mRNA Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China mRNA Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China mRNA Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global mRNA Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 mRNA Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 mRNA Vaccine Industry PEST Analysis

    • 2.3 mRNA Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 mRNA Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on mRNA Vaccine Industry

    Chapter 3 Global and China mRNA Vaccine Market, by Manufacturer

    • 3.1 Global and China mRNA Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China mRNA Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China mRNA Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China mRNA Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China mRNA Vaccine Market Top 3 Players

    Chapter 4 Global and China mRNA Vaccine Market, by Type (2017-2028)

    • 4.1 mRNA Vaccine Market Trend, by Type

    • 4.2 Global mRNA Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global mRNA Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global mRNA Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global mRNA Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China mRNA Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China mRNA Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China mRNA Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China mRNA Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China mRNA Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global mRNA Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global mRNA Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global mRNA Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China mRNA Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China mRNA Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China mRNA Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global mRNA Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America mRNA Vaccine Market Analysis

    • 7.1 North America mRNA Vaccine Market, by Type

    • 7.2 North America mRNA Vaccine Market, by Application

    • 7.3 North America mRNA Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe mRNA Vaccine Market Analysis

    • 8.1 Europe mRNA Vaccine Market, by Type

    • 8.2 Europe mRNA Vaccine Market, by Application

    • 8.3 Europe mRNA Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC mRNA Vaccine Market Analysis

    • 9.1 APAC mRNA Vaccine Market, by Type

    • 9.2 APAC mRNA Vaccine Market, by Application

    • 9.3 APAC mRNA Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa mRNA Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa mRNA Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa mRNA Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa mRNA Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina mRNA Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China mRNA Vaccine Company Profiles

      • 11.1 Argos Therapeutics

        • 11.1.1 Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Argos Therapeutics mRNA Vaccine Product Profiles, Application and Specification

        • 11.1.3 Argos Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ethris

        • 11.2.1 Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ethris mRNA Vaccine Product Profiles, Application and Specification

        • 11.2.3 Ethris mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 eTheRNA

        • 11.3.1 eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 eTheRNA mRNA Vaccine Product Profiles, Application and Specification

        • 11.3.3 eTheRNA mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 BioNTech

        • 11.4.1 BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 BioNTech mRNA Vaccine Product Profiles, Application and Specification

        • 11.4.3 BioNTech mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 In-Cell-Art

        • 11.5.1 In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 In-Cell-Art mRNA Vaccine Product Profiles, Application and Specification

        • 11.5.3 In-Cell-Art mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Moderna Therapeutics

        • 11.6.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Moderna Therapeutics mRNA Vaccine Product Profiles, Application and Specification

        • 11.6.3 Moderna Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Tiba Biotechnology

        • 11.7.1 Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Tiba Biotechnology mRNA Vaccine Product Profiles, Application and Specification

        • 11.7.3 Tiba Biotechnology mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 CureVac

        • 11.8.1 CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 CureVac mRNA Vaccine Product Profiles, Application and Specification

        • 11.8.3 CureVac mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Translate Bio

        • 11.9.1 Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Translate Bio mRNA Vaccine Product Profiles, Application and Specification

        • 11.9.3 Translate Bio mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Sangamo Therapeutics

        • 11.10.1 Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Sangamo Therapeutics mRNA Vaccine Product Profiles, Application and Specification

        • 11.10.3 Sangamo Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 mRNA Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 mRNA Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 mRNA Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China mRNA Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Infection Prevention MRNA Vaccine (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Infectious Disease (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global mRNA Vaccine Market Size and Growth Rate of Other (2017-2028)

    • Figure North America mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global mRNA Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China mRNA Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China mRNA Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China mRNA Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China mRNA Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China mRNA Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China mRNA Vaccine Market Share, by Manufacturer in 2022

    • Table Global mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table Global mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global mRNA Vaccine Sales Value, by Type (2017-2028)

    • Table Global mRNA Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global mRNA Vaccine Price Trend, by Type (2017-2028)

    • Table China mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table China mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China mRNA Vaccine Sales Value, by Type (2017-2028)

    • Table China mRNA Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China mRNA Vaccine Price Trend, by Type (2017-2028)

    • Table Global mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table Global mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global mRNA Vaccine Sales Value, by Application (2017-2028)

    • Table Global mRNA Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global mRNA Vaccine Sales Value Share, by Application (2017-2028)

    • Table China mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table China mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China mRNA Vaccine Sales Value, by Application (2017-2028)

    • Table China mRNA Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa mRNA Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table North America mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table North America mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa mRNA Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina mRNA Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina mRNA Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Argos Therapeutics Product Profiles, Application and Specification

    • Table Argos Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ethris Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ethris Product Profiles, Application and Specification

    • Table Ethris mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table eTheRNA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table eTheRNA Product Profiles, Application and Specification

    • Table eTheRNA mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioNTech Product Profiles, Application and Specification

    • Table BioNTech mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table In-Cell-Art Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table In-Cell-Art Product Profiles, Application and Specification

    • Table In-Cell-Art mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Moderna Therapeutics Product Profiles, Application and Specification

    • Table Moderna Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tiba Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tiba Biotechnology Product Profiles, Application and Specification

    • Table Tiba Biotechnology mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CureVac Product Profiles, Application and Specification

    • Table CureVac mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Translate Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Translate Bio Product Profiles, Application and Specification

    • Table Translate Bio mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sangamo Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sangamo Therapeutics Product Profiles, Application and Specification

    • Table Sangamo Therapeutics mRNA Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US